These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effective prevention of thrombocytopenia using adenovirus-mediated transfer of HST-11FGF-4 gene: in vivo and in vitro studies. Konishi H; Ochiya T; Sakamoto H; Tsukamoto M; Yasuda Y; Muto T; Sugimura T; Terada M Leukemia; 1997 Apr; 11 Suppl 3():530-2. PubMed ID: 9209447 [TBL] [Abstract][Full Text] [Related]
3. Megakaryocytopoiesis in vitro: from the stem cells' perspective. Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587 [TBL] [Abstract][Full Text] [Related]
5. Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene. Konishi H; Ochiya T; Sakamoto H; Tsukamoto M; Saito I; Muto T; Sugimura T; Terada M J Clin Invest; 1995 Aug; 96(2):1125-30. PubMed ID: 7635948 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
7. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness. Mintern J; Williams N; Jackson H Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
9. Effects of megakaryocyte growth and development factor (thrombopoietin) on liver endothelial cells in vitro. Cardier JE Microvasc Res; 1999 Sep; 58(2):108-13. PubMed ID: 10458926 [TBL] [Abstract][Full Text] [Related]
10. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro. Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Su RJ; Li K; Yang M; Zhang XB; Tsang KS; Fok TF; Li CK; Yuen PM Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824 [TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5. Cui L; Ramsfjell V; Borge OJ; Veiby OP; Lok S; Jacobsen SE J Immunol; 1997 Aug; 159(4):1961-9. PubMed ID: 9257862 [TBL] [Abstract][Full Text] [Related]
14. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-3 and Flt3-ligand induce adhesion of Baf3/Flt3 precursor B-lymphoid cells to fibronectin via activation of VLA-4 and VLA-5. Shibayama H; Anzai N; Ritchie A; Zhang S; Mantel C; Broxmeyer HE Cell Immunol; 1998 Jul; 187(1):27-33. PubMed ID: 9682000 [TBL] [Abstract][Full Text] [Related]
16. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496 [TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium. Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of HST-1/FGF-4 gene protects mice from lethal irradiation. Takahama Y; Ochiya T; Tanooka H; Yamamoto H; Sakamoto H; Nakano H; Terada M Oncogene; 1999 Oct; 18(43):5943-7. PubMed ID: 10557081 [TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte development and platelet production. Deutsch VR; Tomer A Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888 [TBL] [Abstract][Full Text] [Related]
20. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Dolzhanskiy A; Basch RS; Karpatkin S Blood; 1997 Jan; 89(2):426-34. PubMed ID: 9002944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]